CC
FPRX

Centiva Capital’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Centiva Capital’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,000
Closed -$565K – 1943
2021
Q1 		$565K Buy
+15,000
New +$374K 0.02% 514

Centiva Capital's FPRX Position: Q2 2021 in Review

Centiva Capital sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 15,000 shares — an estimated $565K sold.

Centiva Capital first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $565K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Centiva Capital reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Centiva Capital sold 15,000 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $565K.
  • Centiva Capital first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • Centiva Capital's Five Prime Therapeutics, Inc. position peaked at $565K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Centiva Capital's 13F filing for Q2 2021, filed 16 Aug 2021.